データなし
データなし
Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals
Yield10 Bioscience GAAP EPS of -$5.04 Misses by $4.01
Yield10 Bioscience 2Q Loss/Shr $5.04 >YTEN
イールド10バイオサイエンス | 10-Q:Q2 2024 四半期報告書
Delisting of Securities of CONX Corp.; Priveterra Acquisition Corp. II; Yield10 Bioscience, Inc.; Aesthetic Medical International Holdings Group Ltd.; Breeze Holdings Acquisition Corp.; Quadro Acquisition One Corp.; DermTech, Inc.; TRACON...
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
データなし
データなし